Medical Xpress - Medical Xpress news tagged with: novo nordiskhttp://medicalxpress.com/
en-usMedical Xpress internet news portal provides the latest news on Health and Medicine.http://cdn.medicalxpress.com/tmpl/v4/img/medx.140px.pngMedical Xpresshttp://medicalxpress.com/
Another drug is approved to help the obeseThe Food and Drug Administration has approved a drug that may be help some of the millions of Americans resolving to lose weight this year.http://medicalxpress.com/news/2015-01-drug-obese.html
Overweight and ObesityMon, 05 Jan 2015 04:32:53 ESTnews339654766FDA clears Novo Nordisk's weight loss drug SaxendaThe Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. It's the first injectable drug approved for weight loss.http://medicalxpress.com/news/2014-12-fda-novo-nordisk-weight-loss.html
MedicationsTue, 23 Dec 2014 17:00:01 ESTnews338575696FDA panel backs Novo Nordisk injection for obesityFederal health experts say a diabetes drug from Novo Nordisk should be approved for a new use in treating obesity.http://medicalxpress.com/news/2014-09-fda-panel-novo-nordisk-obesity.html
MedicationsThu, 11 Sep 2014 17:22:02 ESTnews329674913Novo Nordisk reports profit rise, progress on US drug permitThe world's top insulin maker, Novo Nordisk, reported rising quarterly profits on Thursday and said studies required to release long-acting insulin Tresiba in the US would be completed sooner than previously thought.http://medicalxpress.com/news/2014-08-novo-nordisk-profit-drug.html
OtherThu, 07 Aug 2014 10:00:02 ESTnews326623580More foreign drug firms face scrutiny in China: report (Update)China is reportedly putting more foreign drug firms under scrutiny, state media said Tuesday, days after the conclusion of a police probe into alleged bribery by employees of Britain's GlaxoSmithKline (GSK).http://medicalxpress.com/news/2014-05-foreign-drug-firms-scrutiny-china.html
MedicationsTue, 27 May 2014 03:51:39 ESTnews320381491Intensive insulin rx lowers glycemic variability in early DM(HealthDay)—Short-term intensive insulin therapy (IIT) can improve β-cell function in type 2 diabetes mellitus (T2DM) in association with decreased glycemic variability, according to a study published in the April issue of Diabetes Care.http://medicalxpress.com/news/2014-04-intensive-insulin-rx-lowers-glycemic.html
DiabetesTue, 15 Apr 2014 17:40:01 ESTnews316799250Tretten approved for genetic clotting disorder(HealthDay)—Tretten (coagulation factor XIII A-Subunit recombinant) has been approved by the U.S. Food and Drug Administration to treat a very rare blood clotting disorder called congenital Factor XIII A-Subunit deficiency.http://medicalxpress.com/news/2013-12-tretten-genetic-clotting-disorder.html
MedicationsMon, 23 Dec 2013 18:37:03 ESTnews307046211Novo Nordisk earnings narrowly miss expectationsNovo Nordisk, the world's biggest producer of insulin for diabetes sufferers, posted a quarterly profit that narrowly missed expectations, and issued a cautious outlook for next year on Thursday.http://medicalxpress.com/news/2013-10-novo-nordisk-narrowly.html
MedicationsThu, 31 Oct 2013 07:55:23 ESTnews302424905Novo Nordisk recalls batches of diabetes drugsBatches of Novo Nordisk's diabetes treatments NovoMix 30 FlexPen and Penfill are being recalled, the European Medicines Agency said on Friday.http://medicalxpress.com/news/2013-10-novo-nordisk-recalls-batches-diabetes.html
DiabetesFri, 25 Oct 2013 09:11:32 ESTnews301911084'Cycling' antibiotics might help combat resistance, study suggests(HealthDay)—Doctors might be able to overcome antibiotic-resistant bacteria by swapping out the antibiotics used to treat a patient, providing a "one-two" punch that keeps the germs reeling, a new Danish study suggests.http://medicalxpress.com/news/2013-09-antibiotics-combat-resistance.html
Medical researchThu, 26 Sep 2013 12:50:01 ESTnews299414212New knowledge on molecular mechanisms behind breast cancerResearchers at University of Copenhagen have gained more insight into the molecular mechanisms of importance for, for example, cancer cell growth and metastasis. The research objective is improved and more targeted drugs. The findings have just been published in the scientific journal Molecular Cell.http://medicalxpress.com/news/2013-09-knowledge-molecular-mechanisms-breast-cancer.html
CancerWed, 25 Sep 2013 11:20:02 ESTnews299324766New protein knowledge offers hope for better cancer treatmentWhen the pharmaceutical industry develops new medicines – for example for cancer treatment – it is important to have detailed knowledge of the body's molecular response to the medicine.http://medicalxpress.com/news/2013-09-protein-knowledge-cancer-treatment.html
CancerThu, 19 Sep 2013 12:00:03 ESTnews298810439Liraglutide augments weight loss in pre-type 2 diabetes(HealthDay)—For patients at high risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), liraglutide in additional to calorie restriction is associated with more weight loss and improvements in insulin resistance, glucose tolerance, and some CVD risk factors, according to a study published online July 8 in Diabetes Care.http://medicalxpress.com/news/2013-08-liraglutide-augments-weight-loss-pre-type.html
DiabetesThu, 15 Aug 2013 16:50:01 ESTnews295802221Genetic risk score linked to increased risk of diabetes(HealthDay)—A genetic risk score based on 46 gene variants linked to type 2 diabetes is associated with increases in the risk of type 2 diabetes and declines in glucose control and beta-cell function, according to a study published online July 8 in Diabetes.http://medicalxpress.com/news/2013-07-genetic-score-linked-diabetes.html
DiabetesTue, 30 Jul 2013 06:00:04 ESTnews294379703Treatment helps sex stage a comeback after menopauseA satisfying sex life is an important contributor to older adults' quality of life, but the sexual pain that can come after menopause can rob women and their partners of that satisfaction. Treatment can help restore it, shows a global survey including some 1,000 middle-aged North American men and women, published online today in Menopause, the journal of The North American Menopause Society (NAMS).http://medicalxpress.com/news/2013-06-treatment-sex-stage-comeback-menopause.html
HealthWed, 05 Jun 2013 00:00:02 ESTnews289587384ACP unveils tools to improve care for patients with prediabetes, gout, obesity, and Alzheimer'sThe American College of Physicians (ACP) today unveiled a series of interventions to help patients and physicians manage prediabetes, gout, obesity and weight loss, and Alzheimer's disease.http://medicalxpress.com/news/2013-04-acp-unveils-tools-patients-prediabetes.html
Diseases, Conditions, SyndromesWed, 10 Apr 2013 17:33:52 ESTnews284834024Resveratrol has no effect in healthy obese men, study finds(HealthDay)—Resveratrol appears not to have a metabolic effect in obese men, according to a study published in the April issue of Diabetes.http://medicalxpress.com/news/2013-04-resveratrol-effect-healthy-obese-men.html
DiabetesMon, 08 Apr 2013 18:00:01 ESTnews284661538Should short boys take growth hormone?(HealthDay)—Parents often worry when their child, especially a son, is much shorter than average. But as long as there is no medical cause, parents can rest easy, experts say.http://medicalxpress.com/news/2013-03-short-stature-childhood-discussed.html
HealthWed, 27 Mar 2013 19:12:16 ESTnews283630327US probes new pancreas risks with diabetes drugs (Update)The U.S. Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.http://medicalxpress.com/news/2013-03-fda-probes-pancreas-diabetes-drugs.html
MedicationsThu, 14 Mar 2013 11:21:25 ESTnews282478877Novo Nordisk US shares skid on drug review setback (Update)Shares of Novo Nordisk tumbled Monday after the Danish drugmaker said U.S. regulators need a new study before they can finish their review of two diabetes treatments, a development that could delay approval for several years.http://medicalxpress.com/news/2013-02-novo-nordisk-skid-drug-setback.html
OtherMon, 11 Feb 2013 09:59:42 ESTnews279799166Early menopause tied to greater type 2 diabetes risk(HealthDay)—Women who experience early menopause have a greater risk of type 2 diabetes, according to a study published online Dec. 10 in Diabetes Care.http://medicalxpress.com/news/2012-12-early-menopause-tied-greater-diabetes.html
DiabetesThu, 27 Dec 2012 16:30:01 ESTnews275838867Higher pulse wave velocity seen in well-controlled diabetes(HealthDay)—Pulse wave velocity is higher among patients with well-controlled type 2 diabetes when compared to controls, and is associated with white matter lesions, according to a study published online Nov. 5 in Diabetes Care.http://medicalxpress.com/news/2012-11-higher-pulse-velocity-well-controlled-diabetes.html
DiabetesSat, 10 Nov 2012 07:40:01 ESTnews271749265New study shows gut bacteria could cause type 2 diabetesStudying gut bacteria can reveal a range of human illness. Now, new research shows that the composition of a person's intestinal bacteria could play an important role in the development of type 2 diabetes. These results, from a joint European and Chinese research team, have just been published in the journal Nature.http://medicalxpress.com/news/2012-09-gut-bacteria-diabetes.html
DiabetesWed, 26 Sep 2012 13:00:02 ESTnews267877099Cause of diabetes may be linked to iron transportScientists have been trying to explain the causes of diabetes for many years. Researchers at the University of Copenhagen and Novo Nordisk A/S have now shown that the increased activity of one particular iron-transport protein destroys insulin-producing beta cells. In addition, the new research shows that mice without this iron transporter are protected against developing diabetes. These results have just been published in the prestigious journal Cell Metabolism.http://medicalxpress.com/news/2012-09-diabetes-linked-iron.html
DiabetesThu, 20 Sep 2012 12:20:45 ESTnews267362437Diabetes drugs helps boost Novo Nordisk in Q2(AP) &#151; Danish pharmaceutical company Novo Nordisk A/S says its net profit grew by 29 percent in the second quarter of 2012, chiefly spurred by strong sales of its new diabetes drugs.http://medicalxpress.com/news/2012-08-diabetes-drugs-boost-novo-nordisk.html
OtherThu, 09 Aug 2012 09:29:32 ESTnews263723362Giant raft of data to help us understand diseaseScientists at the Novo Nordisk Foundation Center for Protein Research at the University of Copenhagen have used a new method to assemble a massive catalogue of data on proteins. This gives them unprecedented insight into a process called protein phosphorylation. The research was recently published in the scientific journal Nature Communications.http://medicalxpress.com/news/2012-06-giant-raft-disease.html
Medical researchThu, 28 Jun 2012 09:53:22 ESTnews260095995Scientists study serious immune malfunctionDefects in the gene that encodes the XIAP protein result in a serious immune malfunction. Scientists used biochemical analyses to map the protein's ability to activate vital components of the immune system. Their results have recently been published in Molecular Cell, a journal of international scientific repute.http://medicalxpress.com/news/2012-05-scientists-immune-malfunction.html
ImmunologyThu, 17 May 2012 12:00:06 ESTnews256474758Meds, clinic noncompliance linked to mortality in diabetes(HealthDay) -- Insulin-treated patients with type 2 diabetes who are noncompliant with their medication or clinic appointments face increased all-cause mortality, according to a study published online April 17 in Diabetes Care.http://medicalxpress.com/news/2012-04-meds-clinic-noncompliance-linked-mortality.html
DiabetesTue, 24 Apr 2012 15:00:01 ESTnews254490959CV autonomic neuropathy risk for CVD despite albumin status(HealthDay) -- Cardiovascular autonomic neuropathy (CAN) appears to affect the risk of cardiovascular disease even in type 1 diabetes patients with normal albumin excretion rates, according to a study published online April 12 in Diabetes.http://medicalxpress.com/news/2012-04-cv-autonomic-neuropathy-cvd-albumin.html
CardiologyThu, 19 Apr 2012 04:30:01 ESTnews254024521Supreme Court ruling supports generic drug makers The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.http://medicalxpress.com/news/2012-04-supreme-court-drug-makers.html
MedicationsWed, 18 Apr 2012 00:33:23 ESTnews253927980